Navigation Links
Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
Date:10/4/2007

t clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused ... therapeutics for cardiovascular and muscle disease, today announced ... plays a crucial role in the progression of ... and in neuromuscular synaptic regeneration in mice. ... of the journal Science , reveal miR-206 ...
(Date:12/11/2009)... 11 Ambit Biosciences Corporation announced today the ... D. Anderson Cancer Center of the first patient in ... E fficacy) Phase 2 pivotal trial in ... AC220 is a novel, orally available, potent and ... a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE ...
(Date:12/11/2009)... -- Gwathmey, Inc., a pre-clinical contract research organization ... and cardiovascular disease announces a new CEO. ... Dunn, Ph.D., has joined Gwathmey as Chief Executive ... of experience working with small businesses and the ... Dunn managed multimillion dollar portfolios for the National ...
(Date:12/10/2009)... Corporation (Nasdaq: DNDN ) announced today that it ... of its common stock at a price to the ... to the underwriters a 30-day option to purchase up ... cover overallotments, if any. The offering is expected ... closing conditions. ,, J. P. Morgan Securities Inc. and ...
Breaking Biology Technology:miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3
... Mich., June 24 GeneGo, Inc., the ... VTT has licensed,MetaCore(TM). VTT develops novel high-throughput ... The focus is in investigating,mechanisms of cancer ... exploration of the mechanism of action of,anti-cancer ...
... Md., June 24 Pinnacle Biologics, a private,full-service ... entered into an agreement with Chiltern International, Inc. ... for Western Europe., James R. Miller, President ... the Chiltern agreement represents a significant step in ...
... researchers has developed a technique that controls the number ... procedure considered impossible for the past two decades. , ... deposited potassium atoms onto the surface of a piece ... to continuously manipulate the number of electrons on ultra-thin ...
Other Biology Technology:VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics 2Pinnacle Biologics Announces Contract With Chiltern 2UBC physicists develop 'impossible' technique to study and develop superconductors 2
(Date:12/11/2009)... a cell manage to identify and degrade the diverse ... against serious diseases? The researchers Sabine C. Horn, Professor ... of the Max Delbrck Center for Molecular Medicine (MDC) ... this puzzle. In an enzyme complex that plays a ... discovered a scaffold regulating the identification and disposal of ...
(Date:12/11/2009)... French . , Montreal, December 11, ... mechanism that prevents cancer. In the December 11 edition ... from the Universit de Montral and the Universit de ... prevents the cancer-causing activity of cytokines, hormones that are ... in smokers and people exposed to asbestos. , ...
(Date:12/11/2009)... 11, 2009 Keystone Symposia on Molecular and ... of five new Keystone Symposia Fellows for 2010. ... talented early-career life scientists (postdoctoral trainees or assistant ... process for one year. Fellows are selected based ... commitment to promoting diversity in the biomedical and ...
Breaking Biology News(10 mins):MDC researchers identify a scaffold regulating protein disposal 2Scientists identify natural anti-cancer defenses 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 1Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 2Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 3Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 4Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 5Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 6Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 7Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 8Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 13496 9Seizures Not Epilepsy Itself May Raise Birth Risks 54172 1Seizures Not Epilepsy Itself May Raise Birth Risks 54172 2New Genetic Link Suspected for Muscular Dystrophy 54169 1
... maintained that the domesticated chicken derives from the red jungle ... the wild origins of the chicken are more complicated than ... give most domesticated chickens yellow legs and found to their ... species, the grey jungle fowl. The study is being ...
... 28 ,e-SMART(R) Technologies, Inc., (Pink Sheets: ESMT); with its ... is pleased to,announce that it has signed a contract ... to the SamWon FA Co., Ltd., in Seoul, South,Korea., ... added network),company in South Korea and a leading manufacturer ...
... Option for Voluntary Use of Biometrics, WASHINGTON, ... Legal Workforce today applauded the introduction of,legislation viewed ... system and to helping prevent unauthorized,employment, a key ... The New Employee Verification Act (NEVA) introduced today ...
Other Biology News:Darwin was wrong about the wild origin of the chicken 2e-SMART Technologies Continues Delivery of Its New Super SMART Card in South Korea 2HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 2HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 3
...
RAW; Collected from 8-12 week old sexually mature mice that are free of common parasites; RAW Collected from 8-12 week old sexually mature mice that are free of common parasites....
TP-1 (NDOG1)...
... Endothelin-1 (human, porcine) Endogenous ... endothelin ETA receptor and modulates vascular tonus. ... of three distinct endothelin genes. ET-2 and ... in two and six amino acids, respectively. ...
Biology Products: